Cargando…
IGFBP3 Methylation Is a Novel Diagnostic and Predictive Biomarker in Colorectal Cancer
BACKGROUND AND AIM: Aberrant hypermethylation of cancer-related genes has emerged as a promising strategy for the development of diagnostic, prognostic and predictive biomarkers in human cancer, including colorectal cancer (CRC). The aim of this study was to perform a systematic and comprehensive an...
Autores principales: | Perez-Carbonell, Lucia, Balaguer, Francesc, Toiyama, Yuji, Egoavil, Cecilia, Rojas, Estefania, Guarinos, Carla, Andreu, Montserrat, Llor, Xavier, Castells, Antoni, Jover, Rodrigo, Boland, C. Richard, Goel, Ajay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4134211/ https://www.ncbi.nlm.nih.gov/pubmed/25127039 http://dx.doi.org/10.1371/journal.pone.0104285 |
Ejemplares similares
-
Efficacy of Adjuvant 5-Fluorouracil Therapy for Patients with EMAST-Positive Stage II/III Colorectal Cancer
por: Hamaya, Yasushi, et al.
Publicado: (2015) -
The Clinical Significance of MiR-148a as a Predictive Biomarker in Patients with Advanced Colorectal Cancer
por: Takahashi, Masanobu, et al.
Publicado: (2012) -
Evidence for classification of c.1852_1853AA>GC in MLH1 as a neutral variant for Lynch syndrome
por: Castillejo, Adela, et al.
Publicado: (2011) -
A High Degree of LINE-1 Hypomethylation Is a Unique Feature of Early-Onset Colorectal Cancer
por: Antelo, Marina, et al.
Publicado: (2012) -
Multiple Sporadic Colorectal Cancers Display a Unique Methylation Phenotype
por: Gonzalo, Victoria, et al.
Publicado: (2014)